Nemoclaw
Vendor:
First CVE: Apr 28, 2026 · Active for under a year
2
Total CVEs
More Total CVEs than 53% of tracked products
2.0
Avg CVEs / Year
Higher CVE frequency than 63% of tracked products
7.5
Avg CVSS
Higher Avg CVSS than 52% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Nemoclaw over time
Volume of CVEsAvg CVSS Base Score
First CVE
Apr 28, 2026
2 months ago
Most Recent CVE
Apr 28, 2026
90 days ago
CVE Severity & Scoring
Nemoclaw2 CVEs
50%
50%
All CVEs352,785 CVEs
45%
40%
11%
MediumHigh
Attack Vector
Local1 (50.0%)
Network1 (50.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low2 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (50.0%)
Unknown0 (0.0%)
Required1 (50.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None2 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2026-24222HIGH NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected | Apr 28, 2026 | 8.6 | 33 | NO | NO |
CVE-2026-24231MEDIUM NVIDIA NemoClaw contains a vulnerability in the validateEndpointUrl() SSRF protection component, where an attacker could cause a server-side request forgery by supplying a crafted | Apr 28, 2026 | 6.3 | 25 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (2 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (2 CVEs).
Media Mentions
Signals from CVEs in this product scope (2 CVEs).
Top CNAs Publishing CVEs For Nemoclaw
Top CWEs
Versions
No cataloged versions.